BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 20396373)

  • 1. [Dual-role regulations of canonical Wnt/beta-catenin signaling pathway].
    Liu Y; Zhang CG; Zhou CY
    Beijing Da Xue Xue Bao Yi Xue Ban; 2010 Apr; 42(2):238-42. PubMed ID: 20396373
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The roles of APC and Axin derived from experimental and theoretical analysis of the Wnt pathway.
    Lee E; Salic A; Krüger R; Heinrich R; Kirschner MW
    PLoS Biol; 2003 Oct; 1(1):E10. PubMed ID: 14551908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Reconstituting regulation of the canonical Wnt pathway by engineering a minimal β-catenin destruction machine.
    Pronobis MI; Deuitch N; Posham V; Mimori-Kiyosue Y; Peifer M
    Mol Biol Cell; 2017 Jan; 28(1):41-53. PubMed ID: 27852897
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Mechanism of Wnt signaling pathway regulation by a truncated mutant of Axin2 in colorectal cancer].
    Wang FW; Wen L; Zhu SW; Yao Q; Cai YM; Ma G
    Ai Zheng; 2007 Oct; 26(10):1041-6. PubMed ID: 17927870
    [TBL] [Abstract][Full Text] [Related]  

  • 5. β-catenin as a potential key target for tumor suppression.
    Fu Y; Zheng S; An N; Athanasopoulos T; Popplewell L; Liang A; Li K; Hu C; Zhu Y
    Int J Cancer; 2011 Oct; 129(7):1541-51. PubMed ID: 21455986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mechanism of phosphorylation-dependent binding of APC to beta-catenin and its role in beta-catenin degradation.
    Ha NC; Tonozuka T; Stamos JL; Choi HJ; Weis WI
    Mol Cell; 2004 Aug; 15(4):511-21. PubMed ID: 15327768
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Wilms tumor suppressor WTX negatively regulates WNT/beta-catenin signaling.
    Major MB; Camp ND; Berndt JD; Yi X; Goldenberg SJ; Hubbert C; Biechele TL; Gingras AC; Zheng N; Maccoss MJ; Angers S; Moon RT
    Science; 2007 May; 316(5827):1043-6. PubMed ID: 17510365
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Structural and functional characterization of the Wnt inhibitor APC membrane recruitment 1 (Amer1).
    Tanneberger K; Pfister AS; Kriz V; Bryja V; Schambony A; Behrens J
    J Biol Chem; 2011 Jun; 286(22):19204-14. PubMed ID: 21498506
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Galangin suppresses the proliferation of β-catenin response transcription-positive cancer cells by promoting adenomatous polyposis coli/Axin/glycogen synthase kinase-3β-independent β-catenin degradation.
    Gwak J; Oh J; Cho M; Bae SK; Song IS; Liu KH; Jeong Y; Kim DE; Chung YH; Oh S
    Mol Pharmacol; 2011 Jun; 79(6):1014-22. PubMed ID: 21406604
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plasma membrane recruitment of dephosphorylated beta-catenin upon activation of the Wnt pathway.
    Hendriksen J; Jansen M; Brown CM; van der Velde H; van Ham M; Galjart N; Offerhaus GJ; Fagotto F; Fornerod M
    J Cell Sci; 2008 Jun; 121(11):1793-802. PubMed ID: 18460581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methylation by protein arginine methyltransferase 1 increases stability of Axin, a negative regulator of Wnt signaling.
    Cha B; Kim W; Kim YK; Hwang BN; Park SY; Yoon JW; Park WS; Cho JW; Bedford MT; Jho EH
    Oncogene; 2011 May; 30(20):2379-89. PubMed ID: 21242974
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Casein kinase 1 and Wnt/β-catenin signaling.
    Cruciat CM
    Curr Opin Cell Biol; 2014 Dec; 31():46-55. PubMed ID: 25200911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Alteration of the β-catenin pathway in spiradenoma.
    Im M; Kim DH; Park JS; Chung H; Lee Y; Kim CD; Seo YJ; Lee JH
    J Cutan Pathol; 2011 Aug; 38(8):657-62. PubMed ID: 21518380
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Adenomatous polyposis coli (APC) regulates multiple signaling pathways by enhancing glycogen synthase kinase-3 (GSK-3) activity.
    Valvezan AJ; Zhang F; Diehl JA; Klein PS
    J Biol Chem; 2012 Feb; 287(6):3823-32. PubMed ID: 22184111
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of microtubule actin cross-linking factor 1 (MACF1) in the Wnt signaling pathway.
    Chen HJ; Lin CM; Lin CS; Perez-Olle R; Leung CL; Liem RK
    Genes Dev; 2006 Jul; 20(14):1933-45. PubMed ID: 16815997
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of WNT/beta-CATENIN signaling pathway components in human cumulus cells.
    Wang HX; Tekpetey FR; Kidder GM
    Mol Hum Reprod; 2009 Jan; 15(1):11-7. PubMed ID: 19038973
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IKKalpha stabilizes cytosolic beta-catenin by inhibiting both canonical and non-canonical degradation pathways.
    Carayol N; Wang CY
    Cell Signal; 2006 Nov; 18(11):1941-6. PubMed ID: 16616828
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Axin-independent phosphorylation of APC controls beta-catenin signaling via cytoplasmic retention of beta-catenin.
    Seo E; Jho EH
    Biochem Biophys Res Commun; 2007 May; 357(1):81-6. PubMed ID: 17418091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic alterations of CDH1 and APC genes: relationship with activation of Wnt/beta-catenin pathway in invasive ductal carcinoma of breast.
    Prasad CP; Mirza S; Sharma G; Prashad R; DattaGupta S; Rath G; Ralhan R
    Life Sci; 2008 Aug; 83(9-10):318-25. PubMed ID: 18662704
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lycopene synergistically enhances quinacrine action to inhibit Wnt-TCF signaling in breast cancer cells through APC.
    Preet R; Mohapatra P; Das D; Satapathy SR; Choudhuri T; Wyatt MD; Kundu CN
    Carcinogenesis; 2013 Feb; 34(2):277-86. PubMed ID: 23129580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.